Herspiegel Consulting

Industry Leader – Pharmaceutical & Biotech Consulting

We are a full service pharmaceutical and biotech consulting firm that specializes in new product planning and commercial expertise to optimize product launches and brand performance. Our diverse team has a combined 100+ years of extensive corporate, client and consulting experience in biopharmaceuticals. We leverage our expertise to solve critical business issues, deliver innovative solutions and develop best-in-class deliverables to optimize the value of your brands.

At Herspiegel Consulting, we offer a range of integrative pharmaceutical consulting services, tailored and scaled to meet your brand and business’ needs across a wide variety of therapeutic areas. Our services include pharmaceutical new product planning, product launch preparation, marketing excellence, market access strategy, and market shaping. Industry focus and depth of functional expertise, combined with strong scientific and market knowledge, uniquely position our team to develop achievable strategies and solutions for our clients.

Pharmaceutical marketing capabilities

Explore Our Capabilities

Learn how our customized services can help you meet your brand goals.

Pharmaceutical marketing our perspectives

Hear Our Perspectives

Read our blogs and white papers to learn what’s happening in the healthcare industry.

Pharmaceutical marketing get in touch

Get In Touch

Contact us to learn how Herspiegel Consulting can help your organization.

Latest Blogs

Innovative Drug Pricing via “Netflix Model”

March 1, 2019
Louisiana seeks “Netflix model” for hepatitis C drug pricing In January 2019, the Louisiana ...
Read more

Planning for 505(b)2 Commercial Success

October 17, 2018
Unlike generics and biosimilars, 505(b)2 regulatory products likely involve a unique claim. While 505(b)...
Read more

Fed-Up Hospitals are Starting Their Own Drug Company to Lower Generic Drug Prices

February 12, 2018
The impact of drug shortages is not new within the healthcare system, particularly at the hospital level...
Read more

FDA Continued Rejections of Citizen Petitions Highlights Key Lifecycle Challenges for Biologic Manufacturers

January 24, 2018
Citizen petitions have historically been a tool in the brand manufacturer’s toolkit of “product life...
Read more